ORIC Pharmaceuticals, Inc. (ORIC:NASDAQ) closed at $7.36 on November 20, 2026, down 4.42% on the day. The stock trades 49.9% below its 52-week high of $14.68 and 1.8% above its 52-week low of $7.23. Over the past year, it lost 36.7%. ORIC Pharmaceuticals, Inc. is part of the Health Care sector.
In 252 trading sessions since November 20, 2025, ORIC closed higher on 117 days (46%). Its best day was August 4, 2026 (+27.08%) and its worst was April 1, 2026 (-41.00%). The stock moved 10% or more in a single session 13 times.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely, ORIC-101 and ORIC-533.
Find more stocks like ORIC with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.